Riverside, CT, United States of America

John F Rosen

This inventor holds 1 USPTO granted patent. Top assignee: Elex Analytical Technologies Corp.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John F Rosen. Retrieved from https://idiyas.com/inventor/john-f-rosen-4wrelt5k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John F. Rosen: Innovator in Lead Toxicity Diagnosis

Introduction

John F. Rosen is a notable inventor based in Riverside, CT (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of lead toxicity. His innovative approach has the potential to improve patient outcomes through more accurate diagnosis.

Latest Patents

John F. Rosen holds a patent for a "Method and apparatus for diagnosis of lead toxicity." This invention presents improved methods and apparatus for in vivo measurement of the skeletal lead burden of a patient. The apparatus includes an x-ray tube that emits soft low-energy x-rays from a silver anode, a polarizer for polarizing the emitted x-rays, and a detector for detecting photons fluoresced from atoms in the patient's tibia upon irradiation by the polarized x-rays. The fluoresced photons are spectrally analyzed to determine their energy distribution. Peaks indicating the presence of lead are identified if the patient has relatively high bone lead content. The data may be compared to results from conventional EDTA chelation tests to correlate the findings with accepted medical practices.

Career Highlights

John F. Rosen has dedicated his career to advancing medical technology. His work at Elex Analytical Technologies Corporation has allowed him to focus on innovative solutions for diagnosing lead toxicity. His patent reflects his commitment to improving healthcare through technology.

Collaborations

Some of his notable coworkers include Daniel N. Slatkin and Lucian Wielopolski. Their collaboration has likely contributed to the development and refinement of diagnostic technologies in their field.

Conclusion

John F. Rosen's contributions to the diagnosis of lead toxicity exemplify the impact of innovation in healthcare. His patented methods and apparatus represent a significant advancement in medical diagnostics, potentially leading to better patient care and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…